January 2019 Surety Medicine Teleconference:
IONIZING RADIATION DOSIMETRY AND THE NUCLEAR PRP:
INTERFACES BETWEEN THE HEALTH PHYSICIST AND THE CMA
Wednesday, 16 January
2019 will bring the first Surety Medicine Teleconference of the New Year,
at 1 pm (1300 hrs) Eastern Time. The topic for January is "Ionizing
Radiation Dosimetry and the Nuclear Personnel Reliability Program: Interfaces Between the Health Physicist and
the Competent Medical Authority.” The presenter will be a Health
Physicist Supevisor for an Army Nuclear Personnel Reliability Program work site.
.
SCHEDULE OF UPCOMING SURETY MEDICINE TELECONFERENCES
(subject to change)
| 16 JAN 2019 | Ionizing Radiation Dosimetry and the Nuclear PRP: Interfaces between the Health Physicist and CMA |
|---|
| 20 FEB 2019 | Cardiovascular Screening of Security Guards and Police: PRP and IRP Considerations |
| 20 MAR 2019 | Diagnosis, Evaluation and Treatment of Laboratory-Acquired Botulinum Toxin Exposures |
| 17 APR 2019 | Bloodborne Pathogen Exposures: Pre- and Post-Expsoure Prophylaxis |
| 15 MAY 2019 | Substance Use Disorder Clinical Care (SUDCC) Intake Evaluations for PRP Candidates: Suggested Approach |
| 19 JUN 2019 | Changing Most Probable Event Requirements in the Chemical Storage and
Demilitarization Environment |
| 17 JUL 2019 | The Dental Officer’s Perspective on Supporting the Personnel Reliability Program
|
| 21 AUG 2019 | Certifying Official, Behavioral Health Specialist, and
CMA Interactions: PRP Case Studies
|
| 18 SEP 2019 | Urinary Metabolites, Protein
Adducts and Bio-markers of Nerve and Vesicant Exposures
|
--ALERT--
Auto-Injector Shelf Life Extension Program:
NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM
Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018, and additional lots expired in September 2018! Check any auto-injector medication stores you have. Select the link below for additional information.
The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to
2022. Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page
.
Information on this page also includes the latest updates (03/23/2018) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.
